Gadolinium-based contrast agent

9 marketed 6 in Phase 3

This page covers all Gadolinium-based contrast agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Water proton relaxation (T1 and T2 relaxation times), Water proton relaxation (T1 relaxation time), Water protons (T1 relaxation enhancement).

Targets

Water proton relaxation (T1 and T2 relaxation times) · Water proton relaxation (T1 relaxation time) · Water protons (T1 relaxation enhancement) · Water protons (via paramagnetic gadolinium ion) · Organic anion transporter 1B1/1B3 (OATP1B1/1B3) · Water proton relaxation (T1 relaxation enhancement) · Water protons (paramagnetic enhancement)

Marketed (9)

Phase 3 pipeline (6)